Management of Apixaban for Spinal Injection in Persistent Atrial Fibrillation

Recommended Holding Period

• The American College of Cardiology recommends holding apixaban for at least 48 hours prior to spinal injection procedures in patients with persistent atrial fibrillation, allowing for adequate drug clearance 1, 2, 3

Critical Safety Considerations for Neuraxial Procedures

• The use of indwelling epidural catheters, concomitant NSAIDs or antiplatelet agents, and spinal deformity or prior spinal surgery increase the risk of bleeding in patients undergoing spinal injections 2, 3
• The American College of Cardiology classifies spinal injections as moderate-to-high risk procedures, supporting the 48-hour discontinuation period of apixaban 2

Resumption of Anticoagulation

• The American College of Cardiology recommends resuming apixaban as soon as adequate hemostasis is established after the procedure, without waiting for a specific time interval 4, 1, 2, 3

Thromboembolic Risk Assessment

• The American College of Cardiology recommends assessing stroke risk in patients with persistent atrial fibrillation using clinical factors, including prior stroke/TIA, CHA₂DS₂-VASc score ≥2, and mechanical valves 4, 1, 2, 3

Patient Monitoring

• Patients with renal impairment may require longer holding periods of apixaban, and should be monitored closely for neurological symptoms post-procedure 1, 2, 3